Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.
作者信息
Mahon J
机构信息
Department of Medicine, University of Western Ontario, London.
出版信息
CMAJ. 2000 Apr 4;162(7):1002-4.
Abstract
摘要
相似文献
1
Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.
CMAJ. 2000 Apr 4;162(7):1002-4.
2
Taking critical appraisal to extremes. The need for balance in the evaluation of evidence.
J Fam Pract. 2000 Dec;49(12):1081-5.
3
Highlights of the 2003 Clinical Practice Guidelines for the prevention and management of diabetes in Canada.
CANNT J. 2004 Jan-Mar;14(1):40-3.
4
Diabetes mellitus Canadian clinical practice guidelines update.
CANNT J. 2004 Jul-Sep;14(3):38-44; quiz 44-5.
5
[Evidence-based clinical practice].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2002 Dec;24(6):541-7.
6
Canadian Task Force on the Periodic Health Examination. Annual checkup revisited.
Can Fam Physician. 1996 Sep;42:1637-8, 1648-50.
7
Enough guidelines already.
Can Fam Physician. 1999 Mar;45:573-5.
8
[What is the function of "practice guidelines"?].
Ann Dermatol Venereol. 1999 Mar;126(3):207-9.
9
Scientific evidence and emotional care.
Paediatr Nurs. 1999 Jul;11(6):3.
10
Taking on diabetes. Family doctors on the front lines of the battle against diabetes.
Can Fam Physician. 1998 Nov;44:2345-9, 2356-60.
本文引用的文献
1
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.
CMAJ. 1999 Jun 1;160(11):1593-5; discussion 1595-6.
2
The folly of population screening for type 2 diabetes.
CMAJ. 1999 Jun 1;160(11):1592-3.
3
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6.
4
Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it?
N Engl J Med. 1998 Apr 16;338(16):1153-4; discussion 1154-5. doi: 10.1056/NEJM199804163381612.
5
Management of diabetes mellitus from a public health perspective.
Endocrinol Metab Clin North Am. 1997 Sep;26(3):443-74. doi: 10.1016/s0889-8529(05)70260-7.
6
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.
Diabetes Care. 1997 May;20(5):735-44. doi: 10.2337/diacare.20.5.735.
7
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.
JAMA. 1997 Apr 9;277(14):1159-64.
8
Early photocoagulation in patients with either type I or type II diabetes.
Trans Am Ophthalmol Soc. 1996;94:505-37.
9
Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Arch Intern Med. 1996 Feb 12;156(3):286-9.
10
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.
CMAJ. 1993 Sep 1;149(5):575-84.
Zotero 插件